<DOC>
	<DOCNO>NCT02696590</DOCNO>
	<brief_summary>This study aim evaluate oral injectable route treatment hypovitaminosis D multiple sclerosis ( MS ) patient . The investigator aim assess efficacy method , use Mega dose 600 000 IU D3 , achieve normal serum 25 ( OH ) D level , durability response , practicality possible toxicity .</brief_summary>
	<brief_title>High Dose Oral Versus Intramuscular Vitamin D3 Supplementation In Multiple Sclerosis Patients</brief_title>
	<detailed_description>Ultraviolet sunlight low produce adequate amount vitamin D3 , vitamin D insufficiency last 4 6 month year latitudes ≥42° common individual low vitamin D intake . Vitamin D strong immunoregulatory effect , vitamin D supplementation prevents experimental autoimmune encephalomyelitis ( EAE ) , autoimmune disease animal use model MS . Recently , emerge data epidemiologic study suggest vitamin D may play important role progression development MS. A longitudinal study pediatric MS show 34 % low risk relapse every 10 ng/ml high 25-hydroxyvitamin D level . A similar magnitude reduce relapse risk later report adult MS cohort . Higher vitamin D level also show associate less subsequent inflammatory MS activity brain magnetic resonance imaging ( MRI ) . Finally , study demonstrate patient low vitamin D level MS relapse .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>serum 25 ( OH ) D3 concentration ≤ 20 ng/ml hypercalcaemia , primary hyperparathyroidism , Paget disease , thyrotoxicosis , pregnancy , active malignancy , hypercalciuria , history liver disease , renal insufficiency , clinically apparent malabsorption syndrome , use drug contain vitamin D product , calcium , estrogen drug know affect vitamin D metabolism ( anticonvulsant , glucocorticoid ) receive form supplement contain vitamin D last 6 month . Participants serum 25 ( OH ) D concentration≥ 20 ng/ml</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>